Robert Soiffer
Direttore/Membro del Consiglio presso National Marrow Donor Program
Profilo
Robert Soiffer is currently the Director of Adult Stem Cell Transplantation at Dana-Farber Cancer Institute, Inc. He is also the Director at National Marrow Donor Program and a Professor at Harvard Medical School.
Previously, he was a Member of the Supervisory Board at Kiadis Pharma NV.
He received his undergraduate degree from New York University School of Medicine.
Posizioni attive di Robert Soiffer
| Società | Posizione | Inizio |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | - |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/01/1988 |
National Marrow Donor Program
 National Marrow Donor Program Miscellaneous Commercial ServicesCommercial Services Part of The Marrow Foundation, National Marrow Donor Program is a company that provides treatments for those facing life-threatening blood cancers. The company is based in Minneapolis, MN. The CEO of the company is Amy L. Ronneberg. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Robert Soiffer
| Società | Posizione | Fine |
|---|---|---|
| KIADIS PHARMA N.V. | Direttore/Membro del Consiglio | - |
Formazione di Robert Soiffer
| New York University School of Medicine | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Kiadis Pharma NV
 Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Kiadis Pharma NV engages in pharmaceutical development of cell-based immunotherapy products in the field of diseases of the blood building system. Its lead product is the ATIR101. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
National Marrow Donor Program
National Marrow Donor Program Miscellaneous Commercial ServicesCommercial Services Part of The Marrow Foundation, National Marrow Donor Program is a company that provides treatments for those facing life-threatening blood cancers. The company is based in Minneapolis, MN. The CEO of the company is Amy L. Ronneberg. | Commercial Services |
- Borsa valori
- Insiders
- Robert Soiffer
